Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alireza Hanifehnezhad

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|July 3, 2020
Virolactia in an Asymptomatic Mother with COVID-19Aliye Bastug, Alireza Hanifehnezhad, Cüneyt Tayman, et al.
Viruses|January 20, 2019
Co-Delivery Effect of CD24 on the Immunogenicity and Lethal Challenge Protection of a DNA Vector Expressing Nucleocapsid Protein of Crimean Congo Hemorrhagic Fever VirusTouraj Aligholipour Farzani, Alireza Hanifehnezhad, Katalin Földes, et al.
Advanced Healthcare Materials|April 22, 2025
Tri-Layered Bioactive Cutaneous Scaffold with Integrated Bioactive Metal Organic Frameworks to Promote Full-Thickness Infected Diabetic Wound Healing: Multifaceted Therapeutic StrategiesAyse Gunyakti Mujtaba, Ayşe Karakeçili, Berna Topuz, et al.
Viruses|March 13, 2019
Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice ModelsTouraj Aligholipour Farzani, Katalin Földes, Alireza Hanifehnezhad, et al.
Heliyon|October 5, 2020
Characterization of local SARS-CoV-2 isolates and pathogenicity in IFNAR<sup>-/-</sup> miceAlireza Hanifehnezhad, Ebru Şahin Kehribar, Sıdıka Öztop, et al.
ACS Infectious Diseases|April 15, 2022
A Highly Potent SARS-CoV-2 Blocking Lectin ProteinRecep E Ahan, Alireza Hanifehnezhad, Ebru Ş Kehribar, et al.
Vaccines|September 28, 2024
Immunogenicity and Protective Efficacy of Baculovirus-Expressed SARS-CoV-2 Envelope Protein in Mice as a Universal Vaccine CandidateTuba Çiğdem Oğuzoğlu, Alireza Hanifehnezhad, Saber Delpasand Khabbazi, et al.
EMBO Molecular Medicine|January 22, 2025
FABP4 as a therapeutic host target controlling SARS-CoV-2 infectionHatoon Baazim, Emre Koyuncu, Gürol Tuncman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine|July 3, 2020
Virolactia in an Asymptomatic Mother with COVID-19Aliye Bastug, Alireza Hanifehnezhad, Cüneyt Tayman, et al.
Viruses|January 20, 2019
Co-Delivery Effect of CD24 on the Immunogenicity and Lethal Challenge Protection of a DNA Vector Expressing Nucleocapsid Protein of Crimean Congo Hemorrhagic Fever VirusTouraj Aligholipour Farzani, Alireza Hanifehnezhad, Katalin Földes, et al.
Advanced Healthcare Materials|April 22, 2025
Tri-Layered Bioactive Cutaneous Scaffold with Integrated Bioactive Metal Organic Frameworks to Promote Full-Thickness Infected Diabetic Wound Healing: Multifaceted Therapeutic StrategiesAyse Gunyakti Mujtaba, Ayşe Karakeçili, Berna Topuz, et al.
Viruses|March 13, 2019
Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice ModelsTouraj Aligholipour Farzani, Katalin Földes, Alireza Hanifehnezhad, et al.
Heliyon|October 5, 2020
Characterization of local SARS-CoV-2 isolates and pathogenicity in IFNAR<sup>-/-</sup> miceAlireza Hanifehnezhad, Ebru Şahin Kehribar, Sıdıka Öztop, et al.
ACS Infectious Diseases|April 15, 2022
A Highly Potent SARS-CoV-2 Blocking Lectin ProteinRecep E Ahan, Alireza Hanifehnezhad, Ebru Ş Kehribar, et al.
Vaccines|September 28, 2024
Immunogenicity and Protective Efficacy of Baculovirus-Expressed SARS-CoV-2 Envelope Protein in Mice as a Universal Vaccine CandidateTuba Çiğdem Oğuzoğlu, Alireza Hanifehnezhad, Saber Delpasand Khabbazi, et al.
EMBO Molecular Medicine|January 22, 2025
FABP4 as a therapeutic host target controlling SARS-CoV-2 infectionHatoon Baazim, Emre Koyuncu, Gürol Tuncman, et al.
Pageof 1